Beam Therapeutics Inc. (BEAM) — DEF 14A Filings
All DEF 14A filings from Beam Therapeutics Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Beam Therapeutics Executive Compensation Details
— Apr 18, 2025 Risk: low
Beam Therapeutics Inc. filed its DEF 14A on April 18, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes i -
Beam Therapeutics Inc. files Definitive Proxy Statement for 2024 Annual Meeting
— Apr 19, 2024 Risk: low
Beam Therapeutics Inc. (BEAM) filed a Proxy Statement (DEF 14A) with the SEC on April 19, 2024. Beam Therapeutics Inc. will hold its 2024 Annual Meeting of Stoc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX